Evan Rachlin

Dr Evan Rachlin is a Principal at Blackstone Life Sciences.

Before joining Blackstone in April 2019, Evan was the Head of Strategy at Moderna Therapeutics where he helped complete the largest biotech IPO in history. At Moderna, Evan led the development of the company’s long-range plan, as well as the portfolio strategy and executive equity financings. Before joining Moderna, Evan was a Principal at Bain Capital Ventures where he worked with a number of innovative healthcare IT businesses.

Evan holds a Bachelor of Science, a Doctor of Medicine, and a Master of Business Administration from Harvard University. Evan supports local organizations and serves on the board of the Boston Children's Trust.